Published in J Natl Cancer Inst on August 01, 1978
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol (2008) 1.99
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leuk Lymphoma (2014) 1.77
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
Primary malignant neoplasms associated with chronic lymphocytic leukaemia. Postgrad Med J (1987) 1.65
Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer (1996) 1.13
Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. MedGenMed (2007) 1.04
Synchronously diagnosed lymph nodal collision tumor of malignant melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: case report. Diagn Pathol (2007) 0.93
The implications of an incidental chronic lymphocytic leukaemia in a resection specimen for colorectal adenocarcinoma. World J Surg Oncol (2007) 0.88
Multiple primary cancers in Connecticut, 1935-82. Yale J Biol Med (1987) 0.87
Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study. Br J Cancer (2013) 0.85
Methodologic perspectives on the study of multiple primary cancers. Yale J Biol Med (1987) 0.82
Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia. Mediterr J Hematol Infect Dis (2011) 0.81
Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota. J Am Acad Dermatol (2014) 0.80
Double tumor of the larynx: a case report. Eur Arch Otorhinolaryngol (2002) 0.78
A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol (2012) 0.76
Coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasm. Case Rep Oncol Med (2014) 0.75
Skin cancer in black Americans: a review of 126 cases. J Natl Med Assoc (1987) 0.75
Eyelid carcinoma in patients with systemic lymphoma. J Ophthalmic Vis Res (2010) 0.75
Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Int J Dermatol (2017) 0.75
Second lung malignancy and Richter syndrome in chronic lymphocytic leukemia: case report and literature review. Multidiscip Respir Med (2017) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1996) 3.76
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The emerging epidemic of melanoma and squamous cell skin cancer. JAMA (1989) 2.61
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Mammographic densities and risk of breast cancer. Cancer (1991) 2.47
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Artificial sweeteners and human bladder cancer. Preliminary results. Lancet (1980) 2.42
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Synthetic sweetener consumption and bladder cancer trends in the United States. Nature (1970) 2.05
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst (1995) 2.03
Geographic patterns of oral cancer in the United States: etilogic implications. J Chronic Dis (1977) 2.02
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst (1987) 2.01
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Passive smoking and lung cancer. J Natl Cancer Inst (1986) 1.99
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
A population-based case-control study of thyroid cancer. J Natl Cancer Inst (1987) 1.98
Epidemiology of uterine cervical cancer. J Chronic Dis (1986) 1.97
Epidemiology of human leukemia: recent observations. J Natl Cancer Inst (1967) 1.97
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev (2001) 1.95
Indoor radon and lung cancer in China. J Natl Cancer Inst (1990) 1.95
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res (1991) 1.89